Stage III solid tumor cancer
Showing 1 - 25 of >10,000
Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Sacramento
Recruiting
- Advanced Colorectal Carcinoma
- +15 more
- Fermented Wheat Germ Extract
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Jul 26, 2023
Breast Cancer Stage II, Breast Cancer Stage III, Solid Tumor Trial in Wuxi ([18F]SF-DEVD-2, [18F]-FDG)
Recruiting
- Breast Cancer Stage II
- +2 more
-
Wuxi, Jiangsu, ChinaAffiliated Hospital of Jiangnan University
Apr 22, 2023
Cancer, Melanoma Stage III, Melanoma Stage IV Trial (KB707)
Not yet recruiting
- Cancer
- +6 more
- KB707
- (no location specified)
Jul 24, 2023
Advanced Cholangiocarcinoma, Advanced Hepatocellular Carcinoma, Advanced Malignant Solid Tumor Trial in Los Angeles (Biospecimen
Recruiting
- Advanced Cholangiocarcinoma
- +6 more
- Biospecimen Collection
- +3 more
-
Los Angeles, California
- +1 more
Mar 31, 2023
Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Buffalo (dovitinib lactate,
Completed
- Adenocarcinoma of the Pancreas
- +3 more
- dovitinib lactate
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022
Advanced Breast Carcinoma, Advanced Endometrial Carcinoma, Advanced Fallopian Tube Carcinoma Trial in Houston (biological, drug,
Recruiting
- Advanced Breast Carcinoma
- +73 more
- Atezolizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
May 5, 2022
HER2-negative Breast Cancer, Advanced Solid Tumor Trial in Singapore (ADG106, Doxorubicin, Cyclophosphamide)
Recruiting
- HER2-negative Breast Cancer
- Advanced Solid Tumor
- ADG106
- +3 more
-
Singapore, SingaporeNational University Hospital
Jun 9, 2022
Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in
Active, not recruiting
- Metastatic Melanoma
- +22 more
- Ipilimumab
- +3 more
-
Birmingham, Alabama
- +24 more
Jan 19, 2023
Advanced Endometrial Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston
Recruiting
- Advanced Endometrial Carcinoma
- +36 more
- Glutaminase Inhibitor IPN60090
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Sep 9, 2021
High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai (ctDNA
Recruiting
- High-risk Stage II Colorectal Cancer
- +2 more
- ctDNA methylation dynamic monitoring
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jun 14, 2023
High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai
Recruiting
- High-risk Stage II Colorectal Cancer
- +2 more
- mFOLFIRINOX adjuvant chemotherapy
- mFOLFOX6/XELOX adjuvant chemotherapy
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 12, 2023
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Recruiting
- Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +26 more
- Biopsy
- +5 more
-
Newark, Delaware
- +52 more
Feb 2, 2023
Adult Solid Tumor, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Philadelphia (PD-0332991)
Completed
- Adult Solid Tumor
- +38 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of The University of Pennsylvania
Feb 18, 2021
Stage III NSCLC Trial (Toripalimab, JS004, Pemetrexed)
Not yet recruiting
- Stage III Non-small Cell Lung Cancer
- Toripalimab
- +5 more
- (no location specified)
Jun 3, 2023
Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor, Refractory Ovarian Carcinoma Trial in Houston (TRPV6 Calcium
Recruiting
- Advanced Malignant Solid Neoplasm
- +22 more
- TRPV6 Calcium Channel Inhibitor SOR-C13
-
Houston, TexasM D Anderson Cancer Center
Oct 20, 2022
Malignant Tumor Trial in Chengdu (Oncolytic Virus SDJ001, Oncolytic Virus YD06-1)
Recruiting
- Malignant Tumor
- Oncolytic Virus SDJ001
- Oncolytic Virus YD06-1
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Oct 6, 2023
Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma Trial in Bethesda, Boston (Biopsy,
Recruiting
- Advanced Fallopian Tube Carcinoma
- +21 more
- Biopsy
- +2 more
-
Bethesda, Maryland
- +2 more
Jan 25, 2023
Monitoring T Cell Responses in Melanoma, Lung and Other Cancer
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +9 more
- Biospecimen Collection
- Electronic Health Record Review
-
Rochester, MinnesotaMayo Clinic in Rochester
Oct 4, 2023
Cancer Trial in Taipei (Hitachi's Heavy Ion Beam Therapy System HyBEAT)
Completed
- Cancer
- Hitachi's Heavy Ion Beam Therapy System HyBEAT
-
Taipei, TaiwanCancer Center, Taipei Veterans General Hospital
Mar 9, 2023
Ovarian Cancer Trial in Birmingham (Carboplatin, olaparibp, embro)
Not yet recruiting
- Ovarian Cancer
- Carboplatin
- olaparibp, embro
-
Birmingham, AlabamaO'Neal Comprehensive Cancer Center at UAB
Jul 18, 2023
BRCA1 Gene Mutation, BRCA2 Gene Mutation, Locally Advanced Solid Tumor Trial in New Brunswick, New York (Laboratory Biomarker
Recruiting
- BRCA1 Gene Mutation
- +19 more
- Laboratory Biomarker Analysis
- Pembrolizumab
-
New Brunswick, New Jersey
- +1 more
Nov 16, 2022
Stage II-III Gastric Cancer Trial in Jinan, Qingdao, Yantai (MRD-guided therapy)
Recruiting
- Stage II-III Gastric Cancer
- MRD-guided therapy
-
Jinan, Shandong, China
- +4 more
Nov 27, 2023
NSCLC, Stage III Trial in Indianapolis (Signatera ctDNA test)
Not yet recruiting
- NSCLC, Stage III
- Signatera ctDNA test
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
Mar 13, 2023
Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in
Active, not recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +24 more
- 18F-Fluoromisonidazole
- +4 more
-
La Jolla, California
- +15 more
Jan 3, 2023